A challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate. Instead, the FDA should be conceiving of LLMs as novel forms of intelligence. It should employ similar approaches to those it applies to clinicians.
A challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate. Instead, the FDA should be conceiving of LLMs as novel forms of intelligence. It should employ similar approaches to those it applies to clinicians.Generative AI has arrived in medicine. Normally, when a new device or drug enters the U.S.
Unfortunately, the usual approach to protecting the public and helping doctors and hospitals manage new health care technologies won’t work for generative AI. To realize the full clinical benefits of this technology while minimizing its risks, we will need a regulatory approach as innovative as generative AI itself., MD, is a professor of practice of public health and health policy at the Harvard T.H. Chan School of Public Health.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Can generative AI fix the NHS and boost the nation's health?Generative AI will be transformative for NHS patient outcomes, a senior government advisor says.
Read more »
Harnessing Generative AI For Sustainable Food Systems InnovationI'm a food & agriculture writer exploring the inter-relationship between food and the environment, climate change, human health and economic development.
Read more »
Generative AI Will Replace Everything: Rethinking User ExperienceArran Stewart is the cofounder and CVO of Job.com. Technologist, car nut and proud father. Read Arran Stewart's full executive profile here.
Read more »
Harnessing Generative AI: A $4.4 Trillion Opportunity For The Global EconomyDavid Jones is Vice President, Technology Portfolio at IDA Ireland. Read David Jones' full executive profile here.
Read more »
How Generative AI Will Change Jobs In Customer SupportBernard Marr is a world-renowned futurist, board advisor and author of Generative AI in Practice: 100+ Amazing Ways Generative Artificial Intelligence is Changing Business and Society. He has written over 20 best-selling and award-winning books and advises and coaches many of the world’s best-known organisations.
Read more »
Watch For New Laws That Secretly Contain Fresh Business Opportunities For Startups To Leverage Generative AI, Such As A New Angle On The Use Of Generative AI For LawyersDr. Lance B. Eliot is a world-renowned expert on Artificial Intelligence (AI) with over 7.4+ million amassed views of his AI columns. As a CIO/CTO seasoned executive and high-tech entrepreneur, he combines practical industry experience with deep academic research.
Read more »